Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR–ABL-positive acute lymphoblastic leukemia—retrospective analysis of Polish Adult Leukemia Group (PALG)-Reference-Cited by-同舟云学术

Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR–ABL-positive acute lymphoblastic leukemia—retrospective analysis of Polish Adult Leukemia Group (PALG)

Published:2006-03-08 Issue:6 Volume:85 Page:366-373
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Wrzesień-Kuś A.,Robak T.,Pluta A.,Zwolińska M.,Wawrzyniak E.,Wierzbowska A.,Skotnicki A.,Jakubas B.,Hołowiecki J.,Nowak K.,Kuliczkowski K.,Mazur G.,Haus O.,Dmoszyńska A.,Adamczyk-Cioch M.,Jędrzejczak W. W.,Paluszewska M.,Konopka L.,Pałynyczko G.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-006-0099-z.pdf

Reference23 articles.

1. Avivi I, Goldstone AH (2003) Bone marrow transplant in Ph+ALL patients. Bone Marrow Transplant 31:623–632

2. Boucheix C, David B, Sebban C, Racadot E, Bene MC, Bernard A, Campos L, Jouault H, Sigaux F, Lepage E, Herve P, Fiere D (1994) Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA 87). Blood 84:1603–1612

3. Chao NJ, Blume KG, Forman SJ, Snyder DS (1995) Long-term follow-up of allogeneic bone marrow recipients for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 85:3353–3354

4. Cimino G, Elia L, Mancini M, Annino L, Anaclerico B, Fazi P, Vitale A, Specchia G, Di Raimondo F, Recchia A, Cuneo A, Mecucci C, Pane F, Saglio G, Foa R, Mandelli F (2003) Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome. Blood 102:2014–2020

5. Clavio M, Venturino C, Pierri I, Garrone A, Miglino M, Canepa L, Balleari E, Balocco M, Michelis GL, Ballerini F, Gobbi M (2004) Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia. Ann Hematol 83:696–703

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher incidence of co-expression of BCR-ABL fusion transcripts in an Eastern Indian population;Egyptian Journal of Medical Human Genetics;2023-10-05

2. Outcome of adult acute lymphoblastic leukemia, a single-center experience;Iraqi Journal of Hematology;2022

3. Current Management and New Developments in the Treatment of ALL;Cancer Treatment and Research;2021

4. Maintenance Strategies After Hematopoietic Cell Transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2020-05-19

5. Prognostic significance of a normal karyotype in adult patients with BCR-ABL1-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era;Clinics;2020